Dalbavancin in the treatment of skin and soft tissues infection

Dalbavancin in the treatment of skin and soft tissues infection

Bibliographic Details
Main Authors:	Ana Candela Fajardo, Elena Urbieta Sanz, Cristóbal Gallego Muñoz
Format:	Article
Language:	English
Published:	Grupo Aula Médica 2017-09-01
Series:	Farmacia Hospitalaria
Online Access:	http://www.aulamedica.es/fh/pdf/10800.pdf

Similar Items

Dalbavancin in the treatment of skin and soft tissue infections
by: Nikulin A.A., et al.
Published: (2018-11-01)

Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review
by: Jason W Bennett, et al.
Published: (2008-03-01)

Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
by: Leuthner KD, et al.
Published: (2016-06-01)

New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin
by: Juul JJ, et al.
Published: (2016-02-01)

Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs
by: Pedro Luis Gonzalez, et al.
Published: (2018-12-01)

Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review
by: Luis Buzón-Martín, et al.
Published: (2021-05-01)

Efficacy and safety of dalbavancin in the treatment of Gram-positive bacterial infections
by: Yuhang Wang, et al.
Published: (2021-03-01)

Use of Dalbavancin in Skin, Bone and Joint Infections: A Real-Life Experience in an Italian Center
by: Lucia Brescini, et al.
Published: (2021-09-01)

Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
by: Matthew W. McCarthy, et al.
Published: (2019-11-01)

Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care
by: Leama Ajaka, et al.
Published: (2020-10-01)

Successful use of dalbavancin in the treatment of gram positive blood stream infections: a case series
by: Evins, C., et al.
Published: (2022)

Purulent Skin and Soft Tissue Infection
by: Steven Alexander Kahn MD, et al.
Published: (2010-10-01)

Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature review
by: Morgan Matt, et al.
Published: (2021-06-01)

In vitro activity of Tedizolid and Dalbavancin against MRSA strains is dependent on infection source
by: Maya Azrad, et al.
Published: (2019-01-01)

Multicenter clinical experience of real life Dalbavancin use in gram-positive infections
by: S. Wunsch, et al.
Published: (2019-04-01)

Successful treatment of Enterococcus faecalis bacteremia with dalbavancin as an outpatient in an intravenous drug user
by: Bruce M. Jones, et al.
Published: (2018-11-01)

Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis
by: T. Azamgarhi, et al.
Published: (2019-10-01)

DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
by: Carmen Hidalgo-Tenorio, et al.
Published: (2019-10-01)

New Antibiotics for the Treatment of Acute Bacterial Skin and Soft Tissue Infections in Pediatrics
by: Nicola Principi, et al.
Published: (2020-10-01)

Treatment Failure Outcomes for Emergency Department Patients with Skin and Soft Tissue Infections
by: Larissa S. May, et al.
Published: (2015-10-01)

Skin and soft tissue infection by Mycobacterium intracellulare in an immunocompetent patient
by: Alessio Pampaloni, et al.
Published: (2020-01-01)

Skin and Soft Tissue Infections in Patients with Solid Tumours
by: Diamantis P. Kofteridis, et al.
Published: (2012-01-01)

Topical Antiseptic Formulations for Skin and Soft Tissue Infections
by: Thi Phuong Nga Hoang, et al.
Published: (2021-04-01)

Skin and Soft Tissue Infections (Patera Foot) in Immigrants, Spain
by: Hugo-Guillermo Ternavasio-de la Vega, et al.
Published: (2009-04-01)

In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile
by: Dana Binyamin, et al.
Published: (2018-06-01)

Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization
by: Simonetti O, et al.
Published: (2021-03-01)

Dalbavancin treatment in a deep sternal wound MRSA infection after coronary artery bypass surgery: a case report
by: Aneta GUZEK, et al.
Published: (2018-01-01)

Comparative pharmacoeconomic analysis of ceffaroline fosamil in the treatment of complicated skin and soft tissues infections
by: S. K. Zyryanov, et al.
Published: (2018-05-01)

Dalbavancin versus standard of care for the treatment of osteomyelitis in adults: A retrospective matched cohort study
by: Thamer A. Almangour, et al.
Published: (2020-04-01)

Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections
by: Jacqueline T. Bork, et al.
Published: (2019-05-01)

Community-Associated Methicillin-Resistant Skin and Soft Tissue Infections
by: Limin Wijaya MBBS, MRCP, DTMH, et al.
Published: (2010-09-01)

Trends in US Hospital Admissions for Skin and Soft Tissue Infections
by: John Edelsberg, et al.
Published: (2009-09-01)

Daptomycin (Cubicin) in patients with complicated skin or soft-tissue infections
by: Viola Sacchi
Published: (2008-09-01)

The Prevalence of S. aureus Skin and Soft Tissue Infections in Patients with Pemphigus
by: Zeinab Fagheei Aghmiyuni, et al.
Published: (2016-01-01)

Posttraumatic Skin and Soft-Tissue Infection due to Pseudomonas fulva
by: Fernando Cobo, et al.
Published: (2016-01-01)

Skin and soft tissue infection caused by Basidiobolus spp. in Australia
by: Te-Yu Hung, et al.
Published: (2020-01-01)

Are Blood Cultures Useful in Patients with Skin and Soft Tissue Infections?
by: İlkay BOZKURT
Published: (2018-12-01)

Deprescribing in the chronic terminal patient: statins as an example for reflection
by: Cristóbal Gallego Muñoz, et al.
Published: (2017-11-01)

Treatment strategy for skin and soft tissue infections caused by nontuberculous mycobacteria following various procedures
by: Jae Young Bae, et al.
Published: (2021-01-01)

The Efficacy and Safety of High-dose Daptomycin in the Treatment of Complicated Skin and Soft Tissue Infections in Asians
by: Xiao-meng Dong, et al.
Published: (2020-06-01)